drugset
drugset / Trial / NCT02956772

Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients

NCT02956772 ↗

Phase 2 Unknown 190 enrolled Hunan Provincial People's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

A multicentre, randomized, open-label, parallel-group, active controlled study.

Timeline

Start
2016-11
Primary completion
2019-11
Completion
2020-11

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule 10 mg Intravenous

Indications

hepatocellular carcinoma